Skip to main content
Skip to navigation

Premium members qualification

No comments

Topics

Neurological disorders

No comments

Related articles

Article
Why the blood–brain barrier blocks most drugs – and how ultrasound could help

2026-07-31T06:00:00Z

Contributor Dr Davinder Ramsingh, Drug Target Review
News
Blood test for protein misfolding identifies Alzheimer’s risk years before symptoms

2026-07-29T14:00:00Z

Drug Target Review
News
Landmark fibromyalgia study highlights neurological targets for new therapies

2026-07-28T13:47:00Z

Drug Target Review
News
3D genome reorganisation identified as Alzheimer’s disease molecular hallmark

2026-07-24T10:08:00Z

Drug Target Review
News
Insilico Medicine nominates ISM9528 non-opioid chronic pain candidate using AI

2026-07-23T13:09:00Z

Drug Target Review
Article
How AI and human biology data led to a new addiction drug candidate

2026-07-21T09:36:00Z

Contributor Jayson Uffens, Drug Target Review

No comments yet

You're not signed in.

Only registered users can comment on this article.

Register

Partner content

Webinar
What it takes to automate high-content imaging at scale

2026-03-25T15:00:00

Sponsored by Yokogawa
Article
Women in STEM: resilience and leadership in rare disease research

2026-05-19T09:46:00

Contributor Dr Nitza Thomasson
Article
Why the blood–brain barrier blocks most drugs – and how ultrasound could help

2026-07-31T06:00:00

Contributor Dr Davinder Ramsingh, Drug Target Review
Webinar
The truth about AI in drug discovery: what the experts really think

2026-03-11T14:00:00

Sponsored by Merck
Article
How AI and human biology data led to a new addiction drug candidate

2026-07-21T09:36:00

Contributor Jayson Uffens, Drug Target Review
Whitepaper
ebook: Fluorescence polarization assays

2023-06-30T14:20:35

Sponsored by BPS Bioscience